UCB Pharma (Belgium)

2.2k papers and 68.4k indexed citations i.

About

In recent decades, authors affiliated with UCB Pharma (Belgium) have published 2.2k papers, which have received a total of 68.4k indexed citations. Scholars at this organization have produced 512 papers in Molecular Biology, 424 papers in Psychiatry and Mental health and 357 papers in Cellular and Molecular Neuroscience on the topics of Epilepsy research and treatment (376 papers), Pharmacological Effects and Toxicity Studies (289 papers) and Neuroscience and Neuropharmacology Research (279 papers). Their work is cited by papers focused on Molecular Biology (16.3k citations), Psychiatry and Mental health (15.3k citations) and Cellular and Molecular Neuroscience (13.0k citations). Authors at UCB Pharma (Belgium) collaborate with scholars in Belgium, United States and United Kingdom and have published in prestigious journals including Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences. Some of UCB Pharma (Belgium)'s most productive authors include Henrik Klitgaard, Martin Feelisch, Alain Matagne, Michel Gillard, Vincent Bauchau, Stephen R. Durham, Armel Stockis, Yves Lamberty, Ernst Wülfert and Doru Georg Margineanu.

In The Last Decade

Fields of papers published by authors at UCB Pharma (Belgium)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with UCB Pharma (Belgium) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with UCB Pharma (Belgium) at the time of their publication.

Countries citing scholars working at UCB Pharma (Belgium)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at UCB Pharma (Belgium). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at UCB Pharma (Belgium) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites UCB Pharma (Belgium) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025